Results 301 to 310 of about 1,404,058 (313)

Global cancer statistics, 2012

Ca-A Cancer Journal for Clinicians, 2015
Frank Bray, Rebecca L Siegel, Joannie Lortet-Tieulent   +2 more
exaly  

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

The Lancet, 2016
L. Fehrenbacher, A. Spira, M. Ballinger, M. Kowanetz, J. Vansteenkiste, J. Mazières, Keunchil Park, David C. Smith, Á. Artal-Cortés, C. Lewanski, F. Braiteh, D. Waterkamp, P. He, W. Zou, Daniel S. Chen, J. Yi, A. Sandler, A. Rittmeyer   +17 more
semanticscholar   +1 more source

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

Journal of Clinical Oncology, 2000
F. Shepherd, J. Dancey, R. Ramlau, K. Mattson, R. Gralla, M. O'Rourke, N. Levitan, L. Gressot, M. Vincent, R. Burkes, Susan Coughlin, Yong Kim, J. Bérille   +12 more
semanticscholar   +1 more source

Global cancer statistics

Ca-A Cancer Journal for Clinicians, 2011
Frank Bray
exaly  

Cancer statistics, 2018

Ca-A Cancer Journal for Clinicians, 2018
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal Dvm   +2 more
exaly  

Cancer statistics in China, 2015

Ca-A Cancer Journal for Clinicians, 2016
Rongshou Zheng, Peter D Baade, Siwei Zhang   +2 more
exaly  

Cancer statistics, 2016

Ca-A Cancer Journal for Clinicians, 2016
Rebecca L Siegel, Kimberly D Miller
exaly  

Cancer statistics, 2017

Ca-A Cancer Journal for Clinicians, 2017
Rebecca L Siegel, Kimberly D Miller
exaly  

Cancer statistics, 2015

Ca-A Cancer Journal for Clinicians, 2015
Rebecca L Siegel
exaly  

Cancer statistics, 2013

Ca-A Cancer Journal for Clinicians, 2013
Ahmedin Jemal
exaly